Literature DB >> 29545104

Long-Term Outcome of Portal Vein Stent Placement in Pediatric Liver Transplant Recipients: A Comparison with Balloon Angioplasty.

Dong Jae Shim1, Gi-Young Ko2, Kyu-Bo Sung3, Dong Il Gwon3, Heung Kyu Ko3.   

Abstract

PURPOSE: To evaluate the long-term efficacy of stent placement versus balloon angioplasty for portal vein (PV) stenosis in pediatric liver transplant (LT) recipients.
MATERIALS AND METHODS: Fifty patients (<18 years old; median, 14 months) who underwent percutaneous transhepatic balloon angioplasty (n = 12), transhepatic stent placement (n = 18), or intraoperative transmesenteric stent placement (n = 20) between 1994 and 2015 were retrospectively analyzed. The median intervals from LT to percutaneous transhepatic angioplasty, stent, and intraoperative stent were 145 days (range, 27-2072), 98 days (range, 5-2289), and 0 days (range, 0-14), respectively. The primary study endpoint was the primary patency of each group. Secondary study endpoints included procedural complications, functional stent stenosis, and stent fractures.
RESULTS: The median clinical follow-up periods were 81 months (range, 13-179), 118 months (range, 65-181), and 112 months (range, 47-168) in each group, respectively. In the angioplasty group, the 1-, 5-, and 10-year primary patency rates were all 75% ± 13%. The corresponding rates were all 100% in the percutaneous transhepatic stent group and 90% ± 7%, 90% ± 7%, and 85% ± 8%, respectively, in the intraoperative transmesenteric stent group (P = .103). Major procedural complications occurred in 4 patients, including 1 case with PV tear after percutaneous transhepatic post-stent angioplasty, and 3 cases with acute PV thrombosis after intraoperative transmesenteric stent. Functional stent stenosis and stent fractures occurred in 1 and 2 patients, respectively.
CONCLUSIONS: No statistically significant difference was observed between the 3 groups in terms of the long-term primary patency rates. Therefore, angioplasty should be considered first to treat PV stenosis in pediatric LT recipients.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29545104     DOI: 10.1016/j.jvir.2017.11.019

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  7 in total

1.  Endovascular treatment of surgical mesoportal and portosystemic shunt dysfunction in pediatric patients.

Authors:  Elliot J Stein; Giridhar M Shivaram; Kevin S H Koo; Andre A S Dick; Patrick J Healey; Eric J Monroe
Journal:  Pediatr Radiol       Date:  2019-07-04

2.  Stent insertion and balloon angioplasty for portal vein stenosis after liver transplantation: long-term follow-up results.

Authors:  Kyeong Sik Kim; Jong Man Kim; Ji Soo Lee; Gyu Sung Choi; Jae-Won Cho; Suk-Koo Lee
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

3.  Long-term efficacy and risk factors for stent occlusion in portal vein stent placement: a multi-institutional retrospective study.

Authors:  Hirotsugu Nakai; Hironori Shimizu; Takanori Taniguchi; Seiya Kawahara; Toshihide Yamaoka; Naoya Sasaki; Hiroyoshi Isoda; Yuji Nakamoto
Journal:  CVIR Endovasc       Date:  2022-06-16

Review 4.  The Application of Interventional Radiology in Living-Donor Liver Transplantation.

Authors:  Gi Young Ko; Kyu Bo Sung; Dong Il Gwon
Journal:  Korean J Radiol       Date:  2021-03-09       Impact factor: 3.500

5.  Direct transmesenteric venous interventions in the acute post liver transplant setting.

Authors:  Keshav Anand; Luis Garza; Glenn Halff; Tarunjeet Klair; Francisco Cigarroa; Rajeev Suri; Jorge Lopera
Journal:  J Interv Med       Date:  2020-09-08

6.  Treatment With Balloon Angioplasty of Chronic Portal Vein Thrombosis.

Authors:  Gokhan Tumgor; Sibel Yavuz; Oguz Uskudar; Ugur Ozkan
Journal:  ACG Case Rep J       Date:  2022-03-28

7.  Pediatric split liver transplantation for congenital factor X deficiency: first 10-year follow-up of a case with portal vein stenting.

Authors:  Jung-Man Namgoong; Shin Hwang; Dae-Yeon Kim; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Kyung Mo Kim; Seak Hee Oh
Journal:  Korean J Transplant       Date:  2021-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.